Ribavirin (Copegus, Rebetol, and others)
Combination treatment of HCV with peginterferon alfa and oral ribavirin has produced higher sustained response rates than peginterferon alone and is now considered the regimen of choice for chronic HCV. Patients relapsing after interferon monotherapy may still respond to the combination. Ribavirin is not effective as monotherapy for HCV.